ESTROGENIC SUBSTANCE Drug Patent Profile
When do Estrogenic Substance patents expire, and when can generic versions of Estrogenic Substance launch?
Estrogenic Substance is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in ESTROGENIC SUBSTANCE is estrone. There is one drug master file entry for this compound. Additional details are available on the estrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ESTROGENIC SUBSTANCE?
- What are the global sales for ESTROGENIC SUBSTANCE?
- What is Average Wholesale Price for ESTROGENIC SUBSTANCE?
Summary for ESTROGENIC SUBSTANCE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 106 |
| Patent Applications: | 3,980 |
| DailyMed Link: | ESTROGENIC SUBSTANCE at DailyMed |
US Patents and Regulatory Information for ESTROGENIC SUBSTANCE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | ESTROGENIC SUBSTANCE | estrone | INJECTABLE;INJECTION | 083488-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
